Sector: Professional, Scientific, and Technical Services Industry: Research and Development in Biotechnology (except Nanobiotechnology)
8.235
-0.125
(-1.495%)
Volume:
354,978
52 week range:
5.01 - 12.75
Market Cap:
510.104M
Company Description:
compass pathways is a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health. our first major initiative is developing psilocybin therapy through late-stage clinical trials in the eu and us for patients with treatment-resistant depression. we are developing psychoactive care pathways based on advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.